FIG
FOLD

Fortress Investment Group’s Amicus Therapeutics FOLD Stock Holding History

Fortress Investment Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-245,900
Closed -$3.56M – 34
2026
Q1 		$3.56M Buy
245,900
+135,900
+124% +$1.95M 0.9% 10
2025
Q4 		$1.57M Buy
+110,000
New +$1.08M 0.37% 24

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Fortress Investment Group's FOLD Position: Q2 2026 in Review

Fortress Investment Group sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 245,900 shares — an estimated $3.56M sold.

Fortress Investment Group first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $3.56M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Fortress Investment Group reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Fortress Investment Group sold 245,900 Amicus Therapeutics shares in Q2 2026, an estimated $3.56M.
  • Fortress Investment Group first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
  • Fortress Investment Group's Amicus Therapeutics position peaked at $3.56M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Fortress Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.